机构地区:[1]蚌埠医学院第一附属医院肝胆外科,233004 [2]安徽省第二人民医院肝胆胰外科,合肥233041
出 处:《中华普通外科学文献(电子版)》2021年第6期412-417,共6页Chinese Archives of General Surgery(Electronic Edition)
基 金:安徽省学术和技术带头人及后备人选科研活动经费资助项目(2018D194);安徽省自然科学基金杰出青年项目(2008085J37)。
摘 要:目的探讨胆道支架基础上联合腔内^(125)I粒子置入与传统的姑息性手术(PS)在晚期肝外胆管癌(EHCC)患者中的应用和疗效对比。方法回顾性分析2014年1月至2019年12月在蚌埠医学院第一附属医院肝胆外科入院并接受治疗的晚期EHCC患者136例。根据治疗方式,将患者分为两组:联合组(接受胆道支架联合腔内^(125)I粒子置入术,91例)和PS组(接受开腹胆管空肠吻合联合胆囊切除术,45例)。观察两组患者术后1、3、6个月血清胆红素、转氨酶及白蛋白(ALB)水平的变化;分析比较两组患者住院时间及费用、术后并发症;Kaplan-Meier曲线分析总体生存率(OS)有无差异,Cox回归分析影响患者术后OS的独立因素。结果联合组和PS组患者术后1、3、6个月血清胆红素、转氨酶及ALB水平均较术前有不同程度的改善。两组患者总体并发症发生率差异无统计学意义(P=0.073)。与PS组相比,联合组患者的住院时间显著缩短、住院费用有所降低(均P<0.001),术后OS明显延长(P=0.017)。亚组分析提示,联合治疗在肝门部胆管癌患者中的优势较远端胆管癌更为明显。接受PS治疗(HR=2.665,95%CI:1.544~4.564,P<0.001)、术前血清高CA19-9水平(HR=2.031,95%CI:1.201~3.432,P=0.008)及术前低ALB水平(HR=1.908,95%CI:1.130~3.221,P=0.016)是影响患者术后OS的独立危险因素。结论与传统的PS相比,胆道支架联合腔内^(125)I粒子置入可显著减少晚期EHCC患者的住院时间,降低住院费用及延长生存时间,但不增加总体并发症,值得在临床上进一步推广和应用。Objective To explore and compare the clinical application of biliary stent combined with ^(125)I seeds implantation and palliative surgery(PS)in patients with advanced extrahepatic cholangiocarcinoma(EHCC).Methods 136 advanced EHCC patients,who were admitted into Department of Hepatobiliary Surgery,the First Affiliated Hospital of Bengbu Medical College and received medical treatment between January 2014 and December 2019,were analyzed retrospectively.According to the treatment method,the patients were divided into two groups:combination group(received biliary stent combined with ^(125)I seeds implantation,91 cases)and PS group(underwent open choledochojejunostomy and cholecystectomy,45 cases).The levels of serum bilirubin,aminotransferase and albumin(ALB)were observed at 1,3 and 6 months postoperatively in the two groups.The length of stay,hospital costs,and postoperative overall complications were compared between the two groups.Kaplan-Meier curves were used to analyze the differences in overall survival(OS).Results The serum levels of bilirubin,transaminase,and ALB at 1,3,and 6 months postoperatively were improved in both groups,compared with preoperative values.There was no statistically significant difference in postoperative overall complications between the two groups(P=0.073).Compared with the PS group,the length of stay was significantly shorter(P<0.001),hospital costs were significantly less(P<0.001),OS was significantly better in the combination group(P=0.017).The subgroup analysis further suggested that the advantage of combined therapy was more obvious in patients with hilar cholangiocarcinoma than that in distal cholangiocarcinoma.PS treatment(HR=2.665,95%CI:1.544-4.564,P<0.001),higher preoperative level of carbohydrate antigen 19-9(HR=2.031,95%CI:1.201-3.432,P=0.008)and lower level of ALB(HR=1.908,95%CI:1.130-3.221,P=0.016)were independent predictors of worse OS.Conclusions Compared with PS,biliary stent combined with ^(125)I seeds implantation may significantly shorten the length of stay,reduce ho
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...